Immaculate Amunom

Dr. Immaculate Amunom joined XenoTech in 2008 after completing her Ph.D. in Biochemistry and Molecular Biology from the University of Louisville in Kentucky. She joined the enzyme induction department as a Senior Scientist serving as a study director in multiple in vitro enzyme induction studies in compliance with the FDA Good Laboratory Practices (GLP) and the Organisation for Economic Co-operation and Development (OECD) Principles of GLP. She also served as a Principal Investigator in several ex vivo enzyme induction studies. Dr. Amunom now works in Study Design where she designs and prepared protocols for the different disciplines including Enzyme Induction, Drug Inhibition, Drug Transporters and Drug metabolism (metabolic stability and reaction phenotyping) in compliance with the FDA guidance and the European Medicines Agency (EMA) guideline for the investigation of drug interactions.